Chrysanthe Peteros

Chrysanthe Peteros, MPH, is a seasoned professional in the fields of health policy and pharmaceutical market access, currently serving as Director of Value & Access, Rare Disease at Biogen since November 2021. With a background that includes roles as Associate Director of Value & Access - Business Development and Senior Engagement Manager at PRECISIONadvisors, Chrysanthe has extensive experience in strategic planning, pricing, and market access across various therapy areas and global markets. Prior roles include Senior Analyst at ICON plc, Corporate Medical Summer Graduate Associate at Beacon Health Options, and Health Policy Research Fellow at Fenway Community Health. Chrysanthe holds a B.A. in Italian Language and Literature from Smith College and a Master of Public Health from Boston University.